Related Experiment Videos
The proliferation of prostatic epithelium in chronic prostatitis
Urological Research
|May 30, 1975
Summary
The cell proliferation, measured by labelling index, is significantly higher in chronic prostatitis than in nodular hyperplasia or adenocarcinoma. Accurate assessment requires evaluating individual cells, favoring solid tissue biopsies over cytology.
Area of Science:
- Urology
- Cell Biology
- Pathology
Background:
- Chronic prostatitis exhibits varying cell proliferation rates.
- Distinguishing inflammation-altered cells is crucial for accurate proliferation assessment.
- Previous studies show a higher labelling index in chronic prostatitis compared to other prostate conditions.
Purpose of the Study:
- To compare cell proliferation in chronic prostatitis with nodular hyperplasia and adenocarcinoma.
- To determine the influence of inflammatory foci on cell proliferation measurements.
- To evaluate the suitability of different biopsy types for assessing cell proliferation in prostatitis.
Main Methods:
- Autoradiographical studies were employed.
- Cell proliferation was quantified using the labelling index.
- Comparison between chronic prostatitis, nodular hyperplasia, and differentiated adenocarcinomas was performed.
- Solid tissue biopsies and cytological material were considered.
Main Results:
- The labelling index in chronic prostatitis ranged from 0.7-2.1%.
- This index was markedly higher than in nodular hyperplasia (0.4%) and differentiated adenocarcinomas (0.6%).
- Elevated labelling indices were observed specifically in glands adjacent to inflammatory foci.
Conclusions:
- Chronic prostatitis demonstrates significantly increased cell proliferation compared to benign and malignant prostate tissues.
- Accurate cell proliferation evaluation in chronic prostatitis necessitates assessing individual cells, unaffected by inflammation.
- Solid tissue biopsies are more appropriate than cytological samples for autradiographical studies in chronic prostatitis.